Clinical trial
A Prospective Feasibility Study to Evaluate the Safety and Effectiveness of the ETX-4143 Device in Subjects With Ocular Hypertension
NCT06709300 is registered in ClinicalTrials.gov with EyeCool Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Feasibility Study to Evaluate the Safety and Effectiveness of the ETX-4143 Device in Subjects With Ocular Hypertension
- Lead sponsor
- EyeCool Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- January 31, 2026
- Completion date
- July 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.